In several tumor cells, the p53 gene downregulates ASNS, impacting the balance of intracellular aspartate (Asp) and asparagine (Asn), thereby providing feedback regulation to mediate p53 activation through adenosine monophosphate (AMP)-activated protein kinase (AMPK) phosphorylation [6]. The gene discussed is TP53; the disease is neoplasm.